Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Daniela Adua"'
Publikováno v:
Clinical Management Issues, Vol 4, Iss 1S, Pp 3-7 (2015)
We report the case of a 51-year-old woman with limited Small Cell Lung Cancer (SCLC). Cytological diagnosis has been made by fibroscopy. Chemotherapy schedule was cisplatin 30 mg/mq and VP-16 100 mg/mq days 1,2,3 q21 as first line treatment. The seru
Externí odkaz:
https://doaj.org/article/b25af28d89884b4b849884a47f771108
Autor:
Daniela Adua, Elena Benincasa, Gerardo Rosati, Francesco Di Costanzo, Enzo Maria Ruggeri, Domenico Bilancia, Maria Elena Stroppolo, Carmine Pinto, Patrizia Racca, Libero Ciuffreda, Silvana Chiara, Raimondo Ferrara, Francesca Di Fabio, Ivan Lolli, Lorenzo Antonuzzo
Publikováno v:
Journal of geriatric oncology. 9(3)
The influence of age (70 years and ≥70 years) was retrospectively studied on the quality of life (QoL), incidence of side effects (including skin reactions) and efficacy of chemotherapy plus cetuximab in patients with KRAS wild type (WT) metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8e8d528f8331b33660fa66167222bc3
https://pubmed.ncbi.nlm.nih.gov/29433905
https://pubmed.ncbi.nlm.nih.gov/29433905
Autor:
Giorgio Ercolani, Nicola Normanno, Michelangelo Fiorentino, Annalisa Altimari, Carmine Pinto, Daniela Adua, Fabiola Lorena Rojas Limpe, Antonio Daniele Pinna, Francesca Di Fabio, Elisa Gruppioni
Molecular heterogeneity between primary tumors (PTs) and synchronous resected liver metastasis in colorectal cancer (CRC) has potential relevance in treatment strategies. Next-generation sequencing (NGS) may be able to increase the chances of identif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f8abbeb6a5aa19551fa62f923df26b4
http://hdl.handle.net/11585/621846
http://hdl.handle.net/11585/621846
Autor:
Andrea Ardizzoni, Daniela Adua, Guido Biasco, Maria Laura Artesiani, Claudio Ceccarelli, Luigi Ricciardiello, Lorenzo Montanaro, Franco Bazzoli, Leonardo Henry Eusebi, Massimo Derenzini, Filippo Gustavo Dall'Olio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64f7636b83dbd6818b244f7377958618
http://hdl.handle.net/11585/605310
http://hdl.handle.net/11585/605310
Autor:
Daniela Adua, F. Di Fabio, M. Del Re, Romano Danesi, L. Casolari, A. Ardizzoni, F.L. Rojas Limpe
Publikováno v:
Annals of Oncology. 28:vi12-vi13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39d0b80eda8bfa66991af382976bd00c
https://doi.org/10.1093/annonc/mdx422.032
https://doi.org/10.1093/annonc/mdx422.032
Autor:
Dajana Cuicchi, Silvia Cammelli, Daniela Adua, Lorenzo Fuccio, F. Di Fabio, Andrea Ardizzoni, L. Giaccherini, Gabriella Macchia, Alessio G. Morganti, Alessandra Guido, F. L. Rojas Llimpe
Publikováno v:
Radiotherapy and Oncology. 123:S683-S684
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9daea7ba618e42715c6d85e4e72ba738
https://doi.org/10.1016/s0167-8140(17)31707-3
https://doi.org/10.1016/s0167-8140(17)31707-3
Publikováno v:
Clinical Management Issues; Vol 4, No 1S (2010); 3-7
Clinical Management Issues, Vol 4, Iss 1S, Pp 3-7 (2015)
Clinical Management Issues, Vol 4, Iss 1S, Pp 3-7 (2015)
We report the case of a 51-year-old woman with limited Small Cell Lung Cancer (SCLC). Cytological diagnosis has been made by fibroscopy. Chemotherapy schedule was cisplatin 30 mg/mq and VP-16 100 mg/mq days 1,2,3 q21 as first line treatment. The seru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ff979c754fc7e33e3bc7849d3a50475
https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1064
https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1064
Autor:
Giovanni Mansueto, Daniela Adua, V. Lapadula, Silvia Quadrini, G. Del Bene, Erminio Bonizzoni, Flavia Longo, L. Stumbo, L. De Filippis
Publikováno v:
International Journal of Clinical Practice
SUMMARY Introduction: With repeated courses of chemotherapy, chemotherapy-induced nausea and vomiting (CINV) becomes progressively more difficult to control. The aim of this study was to evaluate whether the antiemetic efficacy of the triple combinat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f1edc6e1b7441b57520b2d7ef3d8d40
https://pubmed.ncbi.nlm.nih.gov/22805267
https://pubmed.ncbi.nlm.nih.gov/22805267
Autor:
Adriana Romiti, Luigi Rossi, Maria Colonna, Marcella Mottolese, Luigi Ruco, Flavia Longo, Daniela Adua, Diana Giannarelli, Federica Zoratto, Viola Barucca, Enzo Veltri, Marisa Di Seri, Silverio Tomao, Angelo Zullo
Aim: The effect of KRAS status on response to bevacizumab plus chemotherapy in metastatic colorectal cancer is still unclear. We aimed to evaluate the overall clinical response to such a therapy in clinical practice and assess the role of KRAS status
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7425b1047dcc2de2379c5bcae9859270
http://hdl.handle.net/11573/507006
http://hdl.handle.net/11573/507006
Autor:
Cristina Mosconi, Cinzia Pettinato, Carmine Pinto, Fabiola Lorena Rojas Llimpe, Renzo Mazzarotto, Barbara Melotti, Claudia Degli Esposti, Alberta Cappelli, Rita Golfieri, Maurizio Levorato, Bruna Angelelli, S. Giaquinta, P.L Guidalotti, Daniela Adua, Fabio Monari, Emanuela Giampalma, Stefano Fanti, V. Mutri, Francesca Di Fabio
Publikováno v:
Journal of Clinical Oncology. 32:e14547-e14547
e14547 Background: Y90 radioembolisation is a promising treatment for chemorefractory CRC liver metastasis patients (pts). This pilot study investigated in a single institution the safety/efficacy ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3420462a9ff097344c7d3bed073c0aa
https://doi.org/10.1200/jco.2014.32.15_suppl.e14547
https://doi.org/10.1200/jco.2014.32.15_suppl.e14547